5th July, 2011 - Dublin, Ireland

Cellix is pleased to announce its expansion and relocation to new premises, located at Longmile Business Park in Dublin.  Following continued growth, Cellix is now expanding to larger premises which comprise laboratory, manufacturing and warehouse together with offices.  This is a positive move for the company accommodating Cellix's growing business needs.

Cellix's head office, together with its Research and Development activities will relocate to these new premises which will also house the company's manufacturing facility.

Should you wish to contact Cellix, our new contact details are:

Cellix Limited,

Unit 1, Longmile Business Park, Longmile Road, Dublin 12, Ireland.

Tel:  +353-1-4500-155.

Email:  This e-mail address is being protected from spambots. You need JavaScript enabled to view it

For details on how to find us; click here.

Dmitry Kashanin, CTO, Cellix commented on the move:  "This is an excellent development for Cellix.  The new facility provides us with space to improve the production process while housing the company headquarters and R&D facilities on-site.  This improves the flow of operations and enables us to work far more efficiently.  Ultimately, it is our customers that will benefit from a better service."

About Cellix:

Cellix is an Irish based company producing a range of precise microfluidic pumping solutions and disposable biochips for cell-based assays in applied biological research and drug screening.  Cellix's VenaFlux Platform and customised platforms provide continuous blood flow (via Mirus Nanopump) and simulate blood vessels (via capillaries in our range of biochips) in a robust in vitro micro-environment.  Investigation of platelet biology, thrombi formation, the leukocyte adhesion cascade; biofilm formation and colonisation; and evaluation of stents and stent materials are key applications of our technology where customers cite the "reduction in blood sample required; ease of use and physiological relevance" of the assays as being of key importance.  Customers include academics, blood centers and pharmaceutical and biotechnology companies around the world.  The Company is headquartered in Dublin, and maintains an office in New York city.  For further information on Cellix's biochip range, click here.

For more information, please contact Cellix: 

Tel:  +353-1-4500-155

Email:     This e-mail address is being protected from spambots. You need JavaScript enabled to view it